生物藥學特論
Biopharmaceutical Sciences
| 節 | 週二 |
|---|---|
3 10:10–11:00 | 生物藥學特論 YC101(陽明) 2 節連堂 |
4 11:10–12:00 |
* 根據陽明交大上課時間表所列
教師未提供此項資料
教師未提供此項資料
無備註
教師未提供此項資料
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | Overview of the FDA approved new drugs 2019/02/19 |
| 第 2 週 | Ageing and Cancer 2019/02/26 |
| 第 3 週 | Metabolomics as the last OMICS; its potential and limitations in translational medicine 2019/03/05 |
| 第 4 週 | From prediabetes to T2DM and diabetic complications: what metabolomics can do 2019/03/12 |
| 第 5 週 | Cancer metabolism and relevant druggable targets 2019/03/19 |
| 第 6 週 | Methodology for drug discovery I: gene knock-down and gene-knockout 2019/03/26 |
| 第 7 週 | Methodology for drug discovery II: principles and application of light microscopy in pharmaceutical sciences 2019/04/02 |
| 第 8 週 | Methodology for drug discovery III: cell-based assay in pharmaceutical research 2019/04/09 |
| 第 9 週 | Midterm and discussion 2019/04/16 |
| 第 10 週 | Anti-microbial agents and drug resistance 2019/04/23 |
| 第 11 週 | Biosimilars 2019/04/30 |
| 第 12 週 | Nutrient sensing pathways as therapeutic targets for healthy ageing 2019/05/07 |
| 第 13 週 | Global Pharma Market Insights 2019/05/14 |
| 第 14 週 | Neurological diseases and pharmaceutical development strategy 2019/05/21 |
| 第 15 週 | Tumor initiating cells and pharmaceutical development strategy 2019/05/28 |
| 第 16 週 | Tumor microenvironment and druggable targets 2019/06/04 |
| 第 17 週 | Personalized T cell-mediated cancer immunotherapy 2019/06/11 |
| 第 18 週 | Final exam and discussion 2019/06/18 |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料
